Health Interventions For The Prevention Of Obesity In Egyptian Children
Launched by KAFRELSHEIKH UNIVERSITY · Apr 18, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to prevent obesity in children living in Gharbia governorate, Egypt. Childhood obesity is a growing problem worldwide, and this study aims to better understand how lifestyle, eating habits, and family factors contribute to this issue. The researchers will work with children aged 6-12 years who are healthy and willing to participate in a health intervention program designed to promote better eating and activity habits.
To participate, children must not have any serious health conditions, like kidney or liver disease, diabetes, or hormonal disorders. Families who agree to take part will receive support and guidance on how to help their children maintain a healthy weight. This study is important because it seeks to tackle obesity at a young age, helping children develop healthier habits that can last a lifetime.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Health children their age between 6-12 years bone and live in Gharbia governorate.
- • Legal pre mission will be taken from each school movement system to assess over weight among there school children.
- • The children and their family included in the study will be able to follow program of health intervention to prevent obesity.
- Exclusion Criteria:
- • have active kidney your hepatic disease.
- • They have any endocrinal or genetic disorders.
- • The have diabetes mellitus and thyroid disease.
- • The children \& their family cannot follow instructions in the program of health interventions included in the study.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, , Egypt
Patients applied
Trial Officials
Mohamed Bedair Ebrahim, professor of physical therapy
Principal Investigator
kafr-elsheikh university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported